Ayako Takigami

Osimertinib, a third‐generation EGFR tyrosine kinase inhibitor: A retrospective multicenter study of its real‐world efficacy and safety in advanced/recurrent non‐small cell lung carcinoma

Takayuki Kishikawa, Takashi Kasai, Masahiko Okada et al. · Thoracic Cancer · 2020 · 38 citations · Full text

Medicine, Oncology, Pharmacology +15

Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy

Masayuki Shirasawa, Tatsuya Yoshida, Kouya Shiraishi et al. · Lung Cancer · 2023 · 29 citations

Medicine, Immunology, Oncology +14

Pazopanib Confers a Progression-free Survival in a Patient with Ewing's Sarcoma/Primitive Neuroectodermal Tumor of the Lung

Ayako Takigami, Hideaki Yamasawa, Ayako Kurosaki et al. · Internal Medicine · 2019 · 21 citations · Full text

Medicine, Oncology, Surgery +17